Monte Rosa Therapeutics terminates ATM stock sale program; no further sales until new prospectus filed

Monte Rosa Therapeutics, Inc.

Effective January 7, 2026, company terminated the ATM prospectus under its shelf registration.
No further sales of common stock under the Sales Agreement unless new prospectus filed.
As of termination date, 2,955,082 shares sold for net proceeds of $24.2 million.
Sales Agreement with Jefferies remains in effect but no sales currently authorized.
Reason for termination not disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.